LifeMD review: pricing, fine print, and how it ranks

The price, in words

On tirzepatide, LifeMD prices out at $597 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, including the mandatory $149/mo membership. That ranks #17 of 17 priced compounded programs — $382 a month above the field's floor (NexLife at $215). Semaglutide runs $348 a month all-in. (#19 of 19 on our semaglutide basis)

What the fine print says

The number to hold onto is the all-in figure: the $149 monthly membership is mandatory, recurs, and belongs in any comparison — advertised medication-only prices here understate the bill. Split pricing: the program fee and the medication are billed separately, so the advertised number is not the billed total. The all-in tirzepatide figure is among the highest we track.

Pharmacy & transparency

Price evidence: Third-party-reported, last verified 2026-08-05. The dispensing pharmacy is not named publicly — the single most common transparency gap in this market. Ask which pharmacy fills the prescription, whether it is 503A or 503B, and whether a certificate of analysis is available; our pharmacy guide explains what each answer means.

The dose ladder, priced rung by rung

The ladder is the easiest math in LifeMD's favor: $597 at 2.5 mg, $597 at 5, $597 at 7.5, $597 at 10, and $597 at 12.5 and 15 — one number, six rungs. The practical consequences compound over a treatment course: the standard four-month climb to 10 mg costs exactly $2,388 (four flat months, no arithmetic), a post-plateau escalation from 10 to 12.5 mg is clinically free, and holding a dose an extra month for tolerability — the standard side-effect play — changes nothing on the bill. Against dose-scaled competitors whose entry figures climb 40–75% by maintenance, and against Zepbound's $299→$449 steps, a flat ladder means the advertised number is the number you keep paying.

What the first year actually bills

Twelve months at the maintenance basis puts LifeMD's first-year spend at $7,164 — twelve identical charges of $597, titration included, because the flat structure makes month one and month twelve the same line item. No prepaid tier is published, so the standing rate is the only rate — simpler, and fully flexible. Benchmarked to the verified floor, the year costs $4,584 more than NexLife's $2,580 — the premium a buyer should be able to name a reason for. Brand context: Zepbound's comparable first year via LillyDirect runs about $5,188 on a standard titration, and $5,388 for a full year already at maintenance.

The 24-month view

Stretch the horizon to 24 months — a realistic treatment arc for a maintenance therapy — and LifeMD's standing-rate ledger reads $14,328. The same 24 months cost $5,160 at the verified floor and $10,776 on brand Zepbound at maintenance — bookends worth writing on the first invoice.

The semaglutide side of the house

Semaglutide here runs $348/month all-in, ranking #19 of 19 on our verified semaglutide basis — against a field floor of $133 (Oak Longevity, with state limits) and brand Wegovy's flat $349. Plan detail worth reading before checkout: Split pricing: about a $149/mo program fee billed separately from medication, so the advertised medication figure is roughly half of the billed total. The in-house premium for stepping up to tirzepatide is $249/month — the local price of SURMOUNT-5's 20.2%-vs-13.7% head-to-head result, and a switch that stays inside one program's intake and pharmacy relationships.

Where it sits in the market

On the verified tirzepatide board, LifeMD's $597 all-in rate ranks #17 of 17: $382/month above the NexLife floor; one rung cheaper sits Eden at $408 (a $189/mo gap). Notably, the rate exceeds Zepbound's $449 FDA-approved maintenance tier by $148/month — a hard sell for a compounded product — the discount a buyer is accepting compounded-product risk to collect. The full board, sortable and dated, is the tirzepatide ranking.

Three buyers, priced honestly

The week-one starter. First month at the 2.5 mg rung: $597 — same as every later month on the flat plan. The 10 mg maintainer. Settled at maintenance, the run-rate is $597/month, $7,164/year — the figure that should anchor any comparison, since it describes years two and three, not the promo. The prepay optimizer. No prepaid tier exists here; the committed-money crowd should compare Found's $169 and NexLife's $186 twelve-month effectives instead.

Nearest alternatives at this price point

If this program's terms don't fit, the same money buys Eden at $408 (source-verified); MEDVi at $399 (flat at every dose, no membership, prepaid to $249); Remedy Meds at $399 (flat at every dose, no membership) — each linked matchup runs the full head-to-head arithmetic on this exact question.

State availability

LifeMD publishes availability of: 50 states. State-by-state context, exceptions, and city coverage live in the 51-state cost guides.

Five questions before checkout

Whatever the marketing says, get answers to: (1) the all-in monthly price at 10 mg and at 12.5 mg, in writing, including every mandatory fee; (2) which pharmacy, by name, fills the prescription — and whether it's 503A or 503B, licensed for your state, with a certificate of analysis available; (3) the cancellation mechanics — deadline relative to renewal, written-confirmation availability, and whether any membership cancels separately. A program that answers all five plainly has already told you most of what this review can.

Visit LifeMD — verify current pricing →Opens the provider’s own pricing page; our figures were captured 2026-08-05.

Bottom line

LifeMD is one of the more expensive tirzepatide programs we track. For context, the verified market floor is $215/mo compounded tirzepatide and $133/mo compounded semaglutide, with brand Zepbound at $449/mo and Wegovy at $349/mo at maintenance.